PT91351A - Processo para a preparacao de derivados de alcoxi-4-(1h)-piridona e de composicoes farmaceuticas que os contem - Google Patents

Processo para a preparacao de derivados de alcoxi-4-(1h)-piridona e de composicoes farmaceuticas que os contem

Info

Publication number
PT91351A
PT91351A PT91351A PT9135189A PT91351A PT 91351 A PT91351 A PT 91351A PT 91351 A PT91351 A PT 91351A PT 9135189 A PT9135189 A PT 9135189A PT 91351 A PT91351 A PT 91351A
Authority
PT
Portugal
Prior art keywords
pharmaceutical compositions
compositions containing
alcoxy
preparation
pyridone derivatives
Prior art date
Application number
PT91351A
Other languages
English (en)
Other versions
PT91351B (pt
Inventor
Julian Aranda
Johannes Hartenstein
Claus Rudolph
Christoph Schachtele
Hartmut Obwald
Reinhard Reck
Guenter Weinheimer
Original Assignee
Goedecke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Goedecke Ag filed Critical Goedecke Ag
Publication of PT91351A publication Critical patent/PT91351A/pt
Publication of PT91351B publication Critical patent/PT91351B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/69—Two or more oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PT91351A 1988-08-06 1989-08-02 Processo para a preparacao de derivados de alcoxi-4-(1h)-piridona e de composicoes farmaceuticas que os contem PT91351B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3826846A DE3826846A1 (de) 1988-08-06 1988-08-06 Alkoxy-4(1h)-pyridon-derivate, verfahren zu deren herstellung und deren verwendung als arzneimittel

Publications (2)

Publication Number Publication Date
PT91351A true PT91351A (pt) 1990-03-08
PT91351B PT91351B (pt) 1997-01-31

Family

ID=6360419

Family Applications (1)

Application Number Title Priority Date Filing Date
PT91351A PT91351B (pt) 1988-08-06 1989-08-02 Processo para a preparacao de derivados de alcoxi-4-(1h)-piridona e de composicoes farmaceuticas que os contem

Country Status (18)

Country Link
US (2) US5185352A (pt)
EP (2) EP0427765B1 (pt)
JP (1) JP2878361B2 (pt)
KR (1) KR920006779B1 (pt)
CN (1) CN1040193A (pt)
AT (1) ATE188469T1 (pt)
AU (1) AU627766B2 (pt)
CA (1) CA1340608C (pt)
DD (1) DD284003A5 (pt)
DE (2) DE3826846A1 (pt)
DK (1) DK174097B1 (pt)
ES (1) ES2144391T3 (pt)
GR (1) GR3033072T3 (pt)
HU (1) HUT56545A (pt)
NO (1) NO177785C (pt)
PT (1) PT91351B (pt)
WO (1) WO1990001477A1 (pt)
ZA (1) ZA895969B (pt)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1283404C (en) * 1986-07-01 1991-04-23 Shigeru Sanai Cephalosporin compounds, processes for their preparation and antibacterial agents
DE3826846A1 (de) * 1988-08-06 1990-02-08 Goedecke Ag Alkoxy-4(1h)-pyridon-derivate, verfahren zu deren herstellung und deren verwendung als arzneimittel
FR2687674B1 (fr) * 1992-02-07 1995-05-19 Roussel Uclaf Nouveaux derives de la pyridone, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
US5674883A (en) * 1992-02-07 1997-10-07 Roussel Uclaf Derivatives of pyridone, their preparation process, the new intermediates obtained, their use as medicaments and the pharmaceutical compositions containing them
DE4243321A1 (de) * 1992-12-21 1994-06-23 Goedecke Ag Aminosäurederivate von Heterocyclen als PKC-Inhibitoren
US6046219A (en) * 1995-01-20 2000-04-04 Cornell Research Foundation, Inc. Method for the treatment of conditions mediated by collagen formation together with cell proliferation by application of inhibitors of protein hydroxylation
US5849587A (en) * 1995-06-09 1998-12-15 Cornell Research Foundation, Inc. Method of inhibiting viral replication in eukaryotic cells and of inducing apoptosis of virally-infected cells
GB2321455A (en) * 1997-01-24 1998-07-29 Norsk Hydro As Lipophilic derivatives of biologically active compounds
US20030017215A1 (en) * 1998-12-07 2003-01-23 Steven M. Bessette Cancer treatment composition and method using natural plant essential oils with signal transduction modulators
US6906068B1 (en) 1999-05-19 2005-06-14 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl 1,2,4 - triazinones useful as anticoagulants
US7015230B1 (en) 1999-05-19 2006-03-21 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascade
US6664255B1 (en) 1999-05-19 2003-12-16 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
US6716838B1 (en) 1999-05-19 2004-04-06 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl uracils as anticoagulative agents
US6867217B1 (en) 1999-05-19 2005-03-15 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade
US6653316B1 (en) 1999-05-19 2003-11-25 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade
US6750342B1 (en) 1999-05-19 2004-06-15 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade
AU2001243598A1 (en) 2000-03-13 2001-09-24 Pharmacia Corporation Polycyclic aryl and heteroaryl substituted benzenes useful for selective inhibition of the coagulation cascade
AU2001251315A1 (en) * 2000-04-05 2001-10-23 Pharmacia Corporation Polycyclic aryl and heteroaryl substituted 4-pyridones useful for selective inhibition of the coagulation cascade
CA2405561A1 (en) 2000-04-05 2001-10-18 Pharmacia Corporation Polycyclic aryl and heteroaryl substituted 4-pyrones useful for selective inhibition of the coagulation cascade
US7119094B1 (en) 2000-11-20 2006-10-10 Warner-Lambert Company Substituted polycyclic aryl and heteroarpyl pyrazinones useful for selective inhibition of the coagulation cascade
US7015223B1 (en) 2000-11-20 2006-03-21 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl 1,2,4-triazinones useful for selective inhibition of the coagulation cascade
WO2002042272A2 (en) 2000-11-20 2002-05-30 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade
CA2462305A1 (en) 2001-10-03 2003-04-10 Michael S. South 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
CA2462645A1 (en) 2001-10-03 2003-11-13 Pharmacia Corporation Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
AU2008232262B2 (en) 2007-03-28 2013-02-14 Apotex Inc. Fluorinated derivatives of deferiprone
US8703156B2 (en) 2008-04-25 2014-04-22 Apotex Technologies Inc. Liquid formulation for deferiprone with palatable taste
AU2010242748B2 (en) 2009-05-01 2015-07-23 Adare Pharmaceuticals, Inc. Orally disintegrating tablet compositions comprising combinations of high and low-dose drugs
MX2012000247A (es) 2009-07-03 2012-03-26 Apotex Technologies Inc Derivados fluorados de 3-hidroxipiridin-4-onas.
WO2016171249A1 (ja) 2015-04-24 2016-10-27 塩野義製薬株式会社 ６員複素環誘導体およびそれらを含有する医薬組成物
JP6692113B2 (ja) * 2016-10-21 2020-05-13 塩野義製薬株式会社 ６員複素環誘導体を含有する医薬組成物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA554715A (en) * 1958-03-18 Boesch Roger Ethers and thioethers and processes for their preparation
US2965641A (en) * 1959-07-06 1960-12-20 Searle & Co Derivatives of 1-(2-aminoethyl)-5-alkoxy-4-pyridones
CA978958A (en) * 1971-10-04 1975-12-02 Haydn W.R. Williams Substituted pyranones and -pyridones and process of manufacture
JPS59110674A (ja) * 1982-12-16 1984-06-26 Ss Pharmaceut Co Ltd ピリジン誘導体及びその製造法
JPS59110675A (ja) * 1982-12-16 1984-06-26 Ss Pharmaceut Co Ltd ピリジン誘導体及びその製造方法
GB8308055D0 (en) * 1983-03-24 1983-05-05 Hider R C Pharmaceutical compositions
CA1283404C (en) * 1986-07-01 1991-04-23 Shigeru Sanai Cephalosporin compounds, processes for their preparation and antibacterial agents
DE3826846A1 (de) * 1988-08-06 1990-02-08 Goedecke Ag Alkoxy-4(1h)-pyridon-derivate, verfahren zu deren herstellung und deren verwendung als arzneimittel

Also Published As

Publication number Publication date
GR3033072T3 (en) 2000-08-31
ATE188469T1 (de) 2000-01-15
KR920006779B1 (ko) 1992-08-17
CN1040193A (zh) 1990-03-07
NO910444L (no) 1991-02-05
DK11391A (da) 1991-01-23
HUT56545A (en) 1991-09-30
ZA895969B (en) 1990-05-30
NO177785C (no) 1995-11-22
NO910444D0 (no) 1991-02-05
DE3826846A1 (de) 1990-02-08
EP0427765A1 (de) 1991-05-22
KR900701755A (ko) 1990-12-04
JP2878361B2 (ja) 1999-04-05
NO177785B (no) 1995-08-14
AU4048989A (en) 1990-03-05
DD284003A5 (de) 1990-10-31
WO1990001477A1 (de) 1990-02-22
JPH04500958A (ja) 1992-02-20
EP0427765B1 (de) 2000-01-05
PT91351B (pt) 1997-01-31
EP0354495A1 (de) 1990-02-14
US5185352A (en) 1993-02-09
DK11391D0 (da) 1991-01-23
AU627766B2 (en) 1992-09-03
DK174097B1 (da) 2002-06-10
DE58909865D1 (de) 2000-02-10
US5322844A (en) 1994-06-21
HU894581D0 (en) 1991-07-29
ES2144391T3 (es) 2000-06-16
CA1340608C (en) 1999-06-22

Similar Documents

Publication Publication Date Title
PT91351A (pt) Processo para a preparacao de derivados de alcoxi-4-(1h)-piridona e de composicoes farmaceuticas que os contem
PT93947A (pt) Processo para a preparacao de novos derivados de maleinimidas e de composicoes farmaceuticas que os contem
DK333788A (da) Farmaceutisk praeparat til behandling af oedelagt bruskvaev
NO963462L (no) Paramunitetinducer basert på kombinasjoner av poxvirus komponenter, fremgangsmåte for fremstilling derav og anvendelse som medikament
IL94278A0 (en) 2-saccharine derivatives,their preparation and pharmaceutical compositions containing them
IT1206112B (it) Nuovi derivati di acidi biliari, procedimento per la loro preparazione e relative composizioni farmaceutiche.
DK505584D0 (da) Administrationssaet og farmaceutiske praeparater til anvendelse dertil
PT99435A (pt) Processo para a preparacao de derivados de amino-sulfonil-ureia e de composicoes farmaceuticas que os contem
FI98703B (fi) Menetelmä hirudiinijohdannaisen valmistamiseksi
NO893504L (no) Fremgangsmaate for fremstilling av transdermalt anvendbarefarmasoeytiske preparater med steroliner og/eller spiroketaliner.
ES2062891T3 (es) Compuestos de 1,2,3,4-oxatriazol-5-imina 3-sustituidos, un proceso para la preparacion de los mismos y un preparado farmaceutico que contiene tales compuestos.
NO863460D0 (no) Fremgangsmaate til fremstilling av 6-fenoksymetyl-4-hydroksy-tetrahydropyran-2-on, fremgangsmaate til deres fremstilling, og deres anvendelse som legemiddel, farmasoeytiske preparater og mellomprodukter.
DK612788D0 (da) Alkoxyderivater af ginkolider, fremgangsmaade til fremstilling heraf og farmaceutiske praeparater indeholdende saadanne forbindelser
PT90337A (pt) Processo para a preparacao de derivados de 6-oxo--piridazina e de composicoes farmaceuticas que os contem
NO904805D0 (no) Fremgangsmaate for fremstilling av antihypertensive og antiarytmiske pyridinderivater.
PT92155A (pt) Processo para a preparacao de derivados de acidos 2-amino-carboxilicos e de composicoes farmaceuticas que os contem
MX9204648A (es) Nuevos derivados de esteres, procedimiento para su preparacion y composicion farmaceutica que los contiene.
NO880663D0 (no) Fremgangsmaate for aa oeke effektiviteten av in vitro vegetativ formering av poteter.
DK190589A (da) Quinolin-3-carboxylsyreforbindelser, fremgangsmaade til fremstilling heraf og farmaceutisk middel omfattende samme
IT8922275A0 (it) Nuovi derivati di corticosteroidi, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
MX6790A (es) Procedimiento para la preparacion de nuevos derivados de aralquilimidazol, productos obtenidos y composicion farmaceutica que los incluye.
IT1213033B (it) Esteri di n-alchil-nortropine eloro derivati ammonioquaternari aventi attivita'anti-broncospastica, procedimento per la loro preparazione e composizioni farmaceutiche che licontengono.
MX12008A (es) Nuevos derivados de amino-acidos, procedimientos para su preparacion de los mismos y composicion farmaceutica que los contiene.
NO893188L (no) Vevnad og fremgangsmaate for fremstilling av denne.
ATE89727T1 (de) Optisch reines dexniguldipin und dessen derivate zur behandlung von tumorerkrankungen.

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19961016

MM3A Annulment or lapse

Effective date: 20060417